Fragment-Based Drug Discovery

Fragment-Based Drug Discovery
Author: Steven Howard
Publisher: Royal Society of Chemistry
Total Pages: 314
Release: 2015-06-17
Genre: Medical
ISBN: 1782625658

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique. This book is written from a Chemist's perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.

Design and Synthesis of (3D) Cyclobutane Fragments for Use in Fragment-based Drug Discovery

Design and Synthesis of (3D) Cyclobutane Fragments for Use in Fragment-based Drug Discovery
Author:
Publisher:
Total Pages: 0
Release: 2023
Genre:
ISBN:

Fragment-based drug discovery (FBDD) has grown into a well-established approach in the pursuit of new therapeutics, and has a growing need for unique screening libraries. Historically, fragment libraries have largely comprised planar compounds with a two-dimensional (2D) shape. It remains to be seen if three-dimensional (3D) fragments could also offer benefits e.g. improved solubility, selectivity, and fragment elaboration. Substantial interest has been placed on the design and synthesis of 3D fragments, and methodology which allows access to or diversification of such scaffolds. To this end, a review providing an overview of 25 synthetic (3D) fragments libraries from recent literature was conducted, providing a comprehensive summary of different collections according to their calculated physicochemical properties and 3D descriptors – fraction sp3 (Fsp3), plane of best fit (PBF) scores and principal moment of inertia (PMI) plots – allowing for fair comparison between different libraries. Initially arising as an intermediate in fragment synthesis, the bromo-cyclobutenaminone scaffold was identified as a novel covalent warhead against a key antibacterial target: UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). Screening a small library of cyclobutenone derivatives led to the identification of bromo-cyclobutenaminones as new covalent inhibitors or MurA. The electrophilic reactivity and cysteine specificity were determined in a glutathione (GSH) and an oligopeptide assay, respectively. Investigating the structure-activity relationship for MurA suggested a crucial role for the bromine atom. In addition, MS/MS experiments proved the covalent labelling of MurA at Cys115 and the observed loss of the bromine atom suggests a net nucleophilic substitution as the covalent reaction. This new set of compounds might be considered as a viable chemical starting point for the discovery of new MurA inhibitors. To address the overpopulation of 2D moieties in fragment libraries, the cyclobutane ring was identified as an underrepresented yet attractive motif which could offer benefits in terms of generating 3D fragments. We report the design and synthesis of a focused set 33 cyclobutane fragments, via a key 3-azido-cyclobutanone building block, giving potential access to a range of functional groups with accessible growth vectors. In this work, the library was designed using Principal Component Analysis (PCA) within Molecular Operating Environment (MOE) and was guided by an expanded version of the rule of three (RO3), followed by Principal Moment of Inertia (PMI) analysis to achieve both chemical diversity and high 3D character. The synthesised cyclobutanol fragments comprised three functionalities at the 3-amino handle: secondary amines, amides, and sulfonamides. Both cis and trans ring isomers of library members were generated, as a means of maximising the shape diversity obtained, while limiting molecular complexity through abrogating enantiomers. Property analyses were conducted, with the cyclobutane library faring favourably against existing synthetic 3D fragment libraries in terms of shape and physicochemical properties. The utility of the cyclobutane fragment library, optimistically, remains to be seen in upcoming screening cascades. Indeed, a mixture of 2D and 3D fragment with a variety of molecular shapes and properties is likely necessary to maximise the chances of finding quality hits for screening cascades.

Diversity Oriented Synthesis

Diversity Oriented Synthesis
Author: Andrea Basso
Publisher: Frontiers Media SA
Total Pages: 150
Release: 2019-03-22
Genre:
ISBN: 2889457885

Has the concept of Diversity Oriented Synthesis remained unchanged over these two decades, or do we observe improvements or deviations from the original guidelines drawn by the pioneers? The aim of this Research Topic is to collect contributions on the state-of-the-art and progress of Diversity Oriented Synthesis, and to foresee its shape in the next decade.

Fragment-based Approaches in Drug Discovery

Fragment-based Approaches in Drug Discovery
Author: Wolfgang Jahnke
Publisher: John Wiley & Sons
Total Pages: 391
Release: 2006-12-13
Genre: Science
ISBN: 3527608605

This first systematic summary of the impact of fragment-based approaches on the drug development process provides essential information that was previously unavailable. Adopting a practice-oriented approach, this represents a book by professionals for professionals, tailor-made for drug developers in the pharma and biotech sector who need to keep up-to-date on the latest technologies and strategies in pharmaceutical ligand design. The book is clearly divided into three sections on ligand design, spectroscopic techniques, and screening and drug discovery, backed by numerous case studies.

Fragment-based Drug Discovery

Fragment-based Drug Discovery
Author: Daniel A. Erlanson
Publisher: John Wiley & Sons
Total Pages: 524
Release: 2016-02-23
Genre: Medical
ISBN: 352733775X

From its origins as a niche technique more than 15 years ago, fragment-based approaches have become a major tool for drug and ligand discovery, often yielding results where other methods have failed. Written by the pioneers in the field, this book provides a comprehensive overview of current methods and applications of fragment-based discovery, as well as an outlook on where the field is headed. The first part discusses basic considerations of when to use fragment-based methods, how to select targets, and how to build libraries in the chemical fragment space. The second part describes established, novel and emerging methods for fragment screening, including empirical as well as computational approaches. Special cases of fragment-based screening, e. g. for complex target systems and for covalent inhibitors are also discussed. The third part presents several case studies from recent and on-going drug discovery projects for a variety of target classes, from kinases and phosphatases to targeting protein-protein interaction and epigenetic targets.

Frontiers in Drug Design and Discovery

Frontiers in Drug Design and Discovery
Author: Atta-ur- Rahman
Publisher: Bentham Science Publishers
Total Pages: 644
Release: 2010-12-13
Genre: Medical
ISBN: 160805201X

"Frontiers in Drug Design and Discovery" is an Ebook series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery inclu

Diversity-Oriented Synthesis

Diversity-Oriented Synthesis
Author: Andrea Trabocchi
Publisher: John Wiley & Sons
Total Pages: 550
Release: 2013-06-17
Genre: Science
ISBN: 1118618149

Discover an enhanced synthetic approach to developing and screening chemical compound libraries Diversity-oriented synthesis is a new paradigm for developing large collections of structurally diverse small molecules as probes to investigate biological pathways. This book presents the most effective methods in diversity-oriented synthesis for creating small molecule collections. It offers tested and proven strategies for developing diversity-oriented synthetic libraries and screening methods for identifying ligands. Lastly, it explores some promising new applications based on diversity-oriented synthesis that have the potential to dramatically advance studies in drug discovery and chemical biology. Diversity-Oriented Synthesis begins with an introductory chapter that explores the basics, including a discussion of the relationship between diversity-oriented synthesis and classic combinatorial chemistry. Divided into four parts, the book: Offers key chemical methods for the generation of small molecules using diversity-oriented principles, including peptidomimetics and macrocycles Expands on the concept of diversity-oriented synthesis by describing chemical libraries Provides modern approaches to screening diversity-oriented synthetic libraries, including high-throughput and high-content screening, small molecule microarrays, and smart screening assays Presents the applications of diversity-oriented synthetic libraries and small molecules in drug discovery and chemical biology, reporting the results of key studies and forecasting the role of diversity-oriented synthesis in future biomedical research This book has been written and edited by leading international experts in organic synthesis and its applications. Their contributions are based on a thorough review of the current literature as well as their own firsthand experience developing synthetic methods and applications. Clearly written and extensively referenced, Diversity-Oriented Synthesis introduces novices to this highly promising field of research and serves as a springboard for experts to advance their own research studies and develop new applications.

Fragment-Based Drug Discovery

Fragment-Based Drug Discovery
Author: Edward R. Zartler
Publisher: John Wiley & Sons
Total Pages: 296
Release: 2008-11-20
Genre: Science
ISBN: 0470721561

Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechnology companies who use fragments as their sole source of drug discovery. Fragment-Based Drug Discovery: A Practical Approach is a guide to the techniques and practice of using fragments in drug screening. The emphasis is on practical guidance, with procedures, case studies, practical tips, and contributions from industry. Topics covered include: an introduction to fragment based drug discovery, why using fragments is a more efficient process than predominant models, and what it means to have a successful FBDD effort. setting up an FBDD project library building and production NMR in fragment screening and follow up application of protein-ligand NOE matching to the rapid evaluation of fragment binding poses target immobilized NMR screening: validation and extension to membrane proteins in situ fragment-based medicinal chemistry: screening by mass spectrometry computational approaches to fragment and substructure discovery and evaluation virtual fragment scanning: current trends, applications and web based tools fragment-based lead discovery using covalent capture methods case study from industry: the identification of high affinity beta-secretase inhibitors using fragment-based lead generation With contributions from industry experts who have successfully set up an industrial fragment-based research program, Fragment-Based Drug Discovery: A Practical Approach offers essential advice to anyone embarking on drug discovery using fragments and those looking for a new approach to screening for drugs.